Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Shares of Edgewise Therapeutics, Inc.  (NASDAQ:EWTX) rose sharply in today's pre-market trading after the company reported topline results from Phase 2 CANYON trial of Sevasemten in individuals with becker muscular dystrophy.

Edgewise Therapeutics shares jumped 26.5% to $35.00 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

Losers

Now Read This:

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.